首頁 > 市場調查報告書 > 醫療設備

生技設備

自動化微生物市場規模、佔有率和成長分析（按樣品類型、產品類型、自動化程度、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1920974

自動化微生物市場規模、佔有率和成長分析（按樣品類型、產品類型、自動化程度、應用、最終用戶和地區分類）－2026-2033年產業預測

Automated Microbiology Market Size, Share, and Growth Analysis, By Sample Type (Blood, Urine), By Product Type (Automated Incubators, Automated Colony Counters), By Automation Level, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月22日 | 出版商:

SkyQuest | 英文 189 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球自動化微生物市場規模預計在 2024 年達到 90 億美元，從 2025 年的 99.9 億美元成長到 2033 年的 230.2 億美元，在預測期（2026-2033 年）內複合年成長率為 11.0%。

由於感染疾病日益普遍，全球自動化微生物市場正經歷顯著成長。醫療相關感染疾病、抗藥性病原體和食源性疾病的增加，推動了對快速、準確的微生物鑑定和藥敏試驗的需求激增。自動化微生物系統利用質譜、基於PCR的檢測和人工智慧驅動的鑑定等先進技術，提高了診斷準確性並縮短了檢測週期。自動化技術在實驗室環境中的應用，提高了營運效率，提升了生產力並加快了處理速度。基於雲端的資料管理實現了即時監控和協作，而對品管和法規遵循的重視，則推動了軟體和設備的進步。供應商和醫療機構之間的合作，促進了診斷檢查室的創新客製化解決方案的開發，進一步支持了市場成長。

全球自動化微生物市場促進因素

全球自動化微生物市場的主要驅動力是醫療機構對快速、準確診斷檢測日益成長的需求。感染疾病的日益流行，以及對病人安全和感染控制的日益重視，正促使醫療機構採用自動化微生物解決方案。這些技術不僅簡化了檢查室流程，還減少了人為錯誤，並能更快提供檢測結果。此外，自動化和人工智慧技術的進步正在提高微生物分析的可靠性和準確性，進一步推動了其在全球醫院、診斷檢查室和研究實驗室的應用。

全球自動化微生物市場限制因素

全球自動化微生物市場的主要限制因素之一是先進自動化系統所需的高額初始投資。小規模檢查室和醫療機構往往面臨預算限制，這限制了它們實施先進微生物自動化技術的能力。此外，專業培訓和維護的需求進一步增加了成本，令潛在採用者望而卻步。這種經濟障礙可能會阻礙自動化解決方案在微生物領域的廣泛應用和發展，尤其是在資源有限的發展中地區。因此，市場普及速度可能會放緩，進而影響該領域的整體成長和創新。

全球自動化微生物市場趨勢

全球自動化微生物市場正經歷重大變革，人工智慧和智慧自動化正在融合，徹底革新傳統的微生物檢測流程。借助先進的機器學習技術，這一趨勢顯著提升了預測性診斷、影像分析和菌落識別能力，大幅提高了準確性並減少了人為誤差。複雜智慧的實驗室生態系的普及進一步促進了診斷決策中的協作與合作。雲端分析和遠端監控解決方案的日益普及有望變革檢查室運營，提高效率並簡化工作流程。自動化與數據智慧的融合，使自動化微生物檢測成為未來醫療保健和診斷的關鍵組成部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

bioMerieux SA
Becton, Dickinson and Company（BD）
Thermo Fisher Scientific Inc.
Danaher Corporation
COPAN Group
Bruker Corporation
Roche Diagnostics
Abbott Laboratories
Rapid Micro Biosystems, Inc.
Merck KGaA
Charles River Laboratories International, Inc.
Siemens Healthineers AG
Agilent Technologies, Inc.
QIAGEN NV
Hologic, Inc.
Bio-Rad Laboratories, Inc.
Synbiosis
Clever Culture Systems（CCS）
Microbiology International
Zhuhai Meihua Medical Technology Ltd.

結論與建議

簡介目錄

Product Code: SQMIG35A3185

Global Automated Microbiology Market size was valued at USD 9.0 billion in 2024 and is poised to grow from USD 9.99 billion in 2025 to USD 23.02 billion by 2033, growing at a CAGR of 11.0% during the forecast period (2026-2033).

The global automated microbiology market is experiencing significant growth driven by the rising prevalence of infectious diseases. The demand for swift and accurate microbiological identification and susceptibility testing has surged due to healthcare-associated infections, antibiotic-resistant pathogens, and foodborne illnesses. Automated microbiology systems enhance diagnostic accuracy and reduce turnaround times using advanced technologies such as mass spectrometry, PCR-based detection, and AI-driven identification. The integration of automation in laboratory settings is revolutionizing operations, ensuring improved productivity and expedited processing. Cloud-based data management facilitates real-time monitoring and collaboration, while a focus on quality control and regulatory compliance propels advancements in software and instruments. Collaborations between suppliers and healthcare providers are fostering the development of innovative, tailored solutions for diagnostic laboratories, further propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Microbiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Microbiology Market Segments Analysis

Global Automated Microbiology Market is segmented by Sample Type, Product Type, Automation Level, Application, End User and region. Based on Sample Type, the market is segmented into Blood, Urine, Tissue, Food and Water. Based on Product Type, the market is segmented into Automated Incubators, Automated Colony Counters, Automated Microbiology Analyzers and Automated Media Preparation Systems. Based on Automation Level, the market is segmented into Semi-Automated and Fully Automated. Based on Application, the market is segmented into Clinical, Food and Beverage, Pharmaceutical and Environmental. Based on End User, the market is segmented into Hospitals and Clinics, Reference Laboratories, Research Institutions, Food and Beverage Companies and Pharmaceutical Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Automated Microbiology Market

A key market driver for the Global Automated Microbiology Market is the increasing demand for rapid and accurate diagnostic testing in healthcare settings. The rising prevalence of infectious diseases, coupled with the growing focus on patient safety and infection control, propels healthcare facilities to adopt automated microbiological solutions. These technologies not only enhance the efficiency of laboratory processes but also reduce human error, leading to quicker turnaround times for test results. Moreover, advancements in automation and artificial intelligence improve the reliability and accuracy of microbiological analyses, further encouraging adoption across hospitals, diagnostics laboratories, and research institutions globally.

Restraints in the Global Automated Microbiology Market

One key market restraint for the global automated microbiology market is the high initial investment required for sophisticated automated systems. Smaller laboratories and healthcare facilities often face budget constraints, limiting their ability to acquire advanced microbiology automation technologies. Additionally, the need for specialized training and maintenance further exacerbates costs, leading to apprehension among potential adopters. This financial barrier can hinder the widespread implementation and growth of automated solutions in microbiology, particularly in developing regions where resources are more limited. As a result, the market may experience slow adoption rates, affecting overall growth and innovation in the sector.

Market Trends of the Global Automated Microbiology Market

The Global Automated Microbiology market is experiencing a significant shift towards the integration of AI and intelligent automation, revolutionizing traditional microbiological processes. Leveraging advanced machine learning techniques, this trend enhances predictive diagnostics, image analysis, and colony recognition, thereby dramatically improving accuracy and reducing human error. The adoption of sophisticated, intelligent lab ecosystems further fosters connectivity and collaboration in diagnostic decision-making. As cloud analytics and remote monitoring solutions gain traction, they promise to transform laboratory operations, driving efficiency and streamlining workflows. This convergence of automation and data intelligence positions automated microbiology as a critical component in the future of healthcare and diagnostics.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Automated Microbiology Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood
Urine
Tissue
Food
Water

Global Automated Microbiology Market Size by Product Type & CAGR (2026-2033)

Market Overview
Automated Incubators
Automated Colony Counters
Automated Microbiology Analyzers
Automated Media Preparation Systems

Global Automated Microbiology Market Size by Automation Level & CAGR (2026-2033)

Market Overview
Semi-Automated
Fully Automated

Global Automated Microbiology Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical
Food and Beverage
Pharmaceutical
Environmental

Global Automated Microbiology Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Reference Laboratories
Research Institutions
Food and Beverage Companies
Pharmaceutical Companies

Global Automated Microbiology Market Size & CAGR (2026-2033)

North America (Sample Type, Product Type, Automation Level, Application, End User)
- US
- Canada
Europe (Sample Type, Product Type, Automation Level, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Sample Type, Product Type, Automation Level, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Sample Type, Product Type, Automation Level, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Sample Type, Product Type, Automation Level, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COPAN Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Micro Biosystems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbiosis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clever Culture Systems (CCS)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbiology International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhuhai Meihua Medical Technology Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments